Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia

被引：2

作者：

Yamada, Yuji ^{[1
]}

Osumi, Tomoo ^{[1
]}

Kato, Motohiro ^{[1
]}

Shioda, Yoko ^{[1
]}

Kiyotani, Chikako ^{[1
]}

Terashima, Keita ^{[1
]}

Hayakawa, Akira ^{[2
,3
]}

Iijima-Yamashita, Yuka ^{[4
]}

Horibe, Keizo ^{[4
]}

Matsumoto, Kimikazu ^{[1
]}

Tomizawa, Daisuke ^{[1
]}

机构：

[1] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[2] Kobe Univ, Dept Pediat, Kobe, Hyogo, Japan

[3] Yodogawa Christians Hosp, Dept Palliat Med, Osaka, Japan

[4] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2022年 / 44卷 / 04期

关键词：

acute promyelocytic leukemia; relapsed; refractory; arsenic trioxide; all-trans retinoic acid; gemtuzumab ozogamicin; ACUTE MYELOID-LEUKEMIA; EVENT-FREE SURVIVAL; ARSENIC TRIOXIDE; ADOLESCENTS; EFFICACY; MYLOTARG; RELAPSE; 1ST; APL;

D O I：

10.1097/MPH.0000000000002404

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is no established treatment for patients with acute promyelocytic leukemia (APL) refractory to targeted therapies with all-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). We report here a case of an 8-month-old girl with APL who failed standard ATRA-combined chemotherapy. Although molecular remission was achieved after introducing ATRA/ATO combination therapy, molecular relapse occurred during the ATO consolidation courses. Subsequent molecular remission was rapidly achieved after administering 2 doses of gemtuzumab ozogamicin. She was successfully treated with unrelated cord blood transplantation using reduced-intensity conditioning. Gemtuzumab ozogamicin might be a preferable choice for patients with APL refractory to standard therapy.

引用

页码：178 / 180

页数：3

共 50 条

[41] Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia
Ustun, Celalettin
Courville, Elizabeth L.
DeFor, Todd
Dolan, Michelle
Randall, Nicole
Yohe, Sophia
Bejanyan, Nelli
Warlick, Erica
Brunstein, Claudio
Weisdorf, Daniel J.
Linden, Michael A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (04) : 669 - 675
[42] Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation
Kondo, Takeshi
Yasumoto, Atsushi
Arita, Kotaro
Sugita, Jun-ichi
Shigematsu, Akio
Okada, Kohei
Takahata, Mutsumi
Onozawa, Masahiro
Kahata, Kaoru
Takeda, Yukari
Obara, Masato
Yamamoto, Satoshi
Endo, Tomoyuki
Nishio, Mitsufumi
Sato, Norihiro
Tanaka, Junji
Hashino, Satoshi
Koike, Takao
Asaka, Masahiro
Imamura, Masahiro
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 310 - 321
[43] Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up
Warlick, Erica Dahl
DeFor, Todd E.
Bejanyan, Nelli
HoItan, Shernan
MacMillan, Margaret
Blazar, Bruce R.
Dusenbery, Kathryn
Arora, Mukta
Bachanova, Veronika
Cooley, Sarah
Lazaryan, Aleksandr
McGlaye, Philip
Miller, Jeffrey S.
Rashidi, Armin
Slungaard, Arne
Vercellotti, Gregory
Ustun, Celalettin
Brunsein, Claudio
Weisdorf, Daniel
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 56 - 62
[44] Graft Manipulation and Reduced-intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation From Mismatched Unrelated and Mismatched/Haploidentical Related Donors in Pediatric Leukemia Patients
Gonzalez-Vicent, Marta
Perez, Antonio
Abad, Lorea
Sevilla, Julian
Ramirez, Manuel
Diaz, Miguel A.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (03) : E85 - E90
[45] Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors
Lee, Kyoo-Hyung
Choi, Seong-Jun
Lee, Je-Hwan
Lee, Jung-Hee
Kim, Dae-Young
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Yun, Sung-Cheol
Joo, Young-Don
Lee, Won-Sik
Kang, Myoung-Joo
Kim, Hawk
Park, Jae-Hoo
Bae, Sung-Hwa
Ryoo, Hun-Mo
Kim, Min-Kyoung
Hyun, Myung-Soo
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (05) : 399 - 405
[46] Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
Gao, Li
Gao, Lei
Gong, Yi
Zhang, Cheng
Chen, Xing-Hua
Zhang, Xi
LEUKEMIA RESEARCH, 2013, 37 (11) : 1482 - 1487
[47] Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
Lee, Kyoo-Hyung
Lee, Je-Hwan
Lee, Jung-Hee
Kim, Dae-Young
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Hwang, Hyun-Ju
Jung, Ah-Rang
Kim, Sung-Han
Yun, Sung-Cheol
Shin, Ho-Jin
BLOOD, 2011, 118 (09) : 2609 - 2617
[48] Pulmonary Veno-occlusive Disease Following Reduced-intensity Allogeneic Bone Marrow Transplantation for Acute Myeloid Leukemia
Hosokawa, Kohei
Yamazaki, Hirohito
Nishitsuji, Masaru
Kobayashi, Satoshi
Takami, Akiyoshi
Fujimura, Masaki
Nakao, Shinji
INTERNAL MEDICINE, 2012, 51 (02) : 195 - 198
[49] Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with High-Risk Leukemia Using a Reduced-Intensity Conditioning Regimen and Peripheral Blood as the Stem Cell Source
Maria Trujillo, Angela
Karduss, Amado J.
Suarez, Gloria
Perez, Rosendo
Ruiz, Giovanni
Cardona, Angelica
Ramirez, Monica
Betancur, Jose
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 427.e1 - 427.e7
[50] Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia
Blaise, Didier
Vey, Norbert
Faucher, Catherine
Mohty, Mohamad
HAEMATOLOGICA, 2007, 92 (04) : 533 - 541

← 1 2 3 4 5 →